Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Thiostrepton by RS Oncology for Non-Small Cell Lung Cancer: Likelihood of Approval
Thiostrepton is under clinical development by RS Oncology and currently in Phase II for Non-Small Cell Lung Cancer. According to...